Identification of the membrane receptor for the complement fragment C3d by means of a monoclonal antibody.
about
Human complement receptor 2 (CR2/CD21) as a receptor for DNA: implications for its roles in the immune response and the pathogenesis of systemic lupus erythematosus (SLE)Epstein Barr virus/complement C3d receptor is an interferon alpha receptorIdentification of a partial cDNA clone for the C3d/Epstein-Barr virus receptor of human B lymphocytes: homology with the receptor for fragments C3b and C4b of the third and fourth components of complementT lymphocyte expression of complement receptor 2 (CR2/CD21): a role in adhesive cell-cell interactions and dysregulation in a patient with systemic lupus erythematosus (SLE)Intersection of the complement and immune systems: a signal transduction complex of the B lymphocyte-containing complement receptor type 2 and CD19Herpes simplex virus glycoproteins gC-1 and gC-2 bind to the third component of complement and provide protection against complement-mediated neutralization of viral infectivityStructure of the human B lymphocyte receptor for C3d and the Epstein-Barr virus and relatedness to other members of the family of C3/C4 binding proteinsMapping of the C3d ligand binding site on complement receptor 2 (CR2/CD21) using nuclear magnetic resonance and chemical shift analysis.Epstein-Barr virus (EBV) infection of murine L cells expressing recombinant human EBV/C3d receptorBiophysical investigations of complement receptor 2 (CD21 and CR2)-ligand interactions reveal amino acid contacts unique to each receptor-ligand pairCR2+ marginal zone B cell production of pathogenic natural antibodies is C3 independentCD19, CD21, and CD22: multifaceted response regulators of B lymphocyte signal transduction.Biosynthesis of the human C3b/C4b receptor during differentiation of the HL-60 cell line. Identification and characterization of a precursor molecule.A new mouse anti-mouse complement receptor type 2 and 1 (CR2/CR1) monoclonal antibody as a tool to study receptor involvement in chronic models of immune responses and disease.Neutrophil mobilization induced by complement fragments during experimental group B streptococcal (GBS) infectionLymphocyte compartments in human spleen. An immunohistologic study in normal spleens and uninvolved spleens in Hodgkin's disease.Follicular large cell lymphoma. An immunophenotype studyImmunohistologic characterization of two malignant lymphomas of germinal center type (centroblastic/centrocytic and centrocytic) with monoclonal antibodies. Follicular and diffuse lymphomas of small-cleaved-cell type are related but distinct entitieIdentification of a 145,000 Mr membrane protein as the C3d receptor (CR2) of human B lymphocytes.Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2.Organization of the genes encoding complement receptors type 1 and 2, decay-accelerating factor, and C4-binding protein in the RCA locus on human chromosome 1.Epstein-Barr virus regulates activation and processing of the third component of complement.Expression of a human cytomegalovirus receptor correlates with infectibility of cells.Characterization of a T-lymphocyte Epstein-Barr virus/C3d receptor (CD21).Identification and characterization of the Epstein-Barr virus receptor on human B lymphocytes and its relationship to the C3d complement receptor (CR2)Pneumococcal polysaccharides complexed with C3d bind to human B lymphocytes via complement receptor type 2Identification of C3d receptors on Candida albicans.C3d adjuvant activity is reduced by altering residues involved in the electronegative binding of C3d to CR2.Molecular structure and expression of anthropic, ovine, and murine forms of complement receptor type 2.Complement-dependent cellular cytotoxicity: lymphoblastoid lines that activate complement component 3 (C3) and express C3 receptors have increased sensitivity to lymphocyte-mediated lysis in the presence of fresh human serumIdentification of an additional class of C3-binding membrane proteins of human peripheral blood leukocytes and cell lines.gp140, the C3d receptor of human B lymphocytes, is also the Epstein-Barr virus receptor.Role of the Bp35 cell surface polypeptide in human B-cell activation.B-cell monoclonal antibodies and their use in clinical oncology.Mapping of the C3d receptor (CR2)-binding site and a neoantigenic site in the C3d domain of the third component of complement.Identification of a third component of complement-binding glycoprotein of human platelets.Spontaneous germinal centers and autoimmunity.Human regulator of complement activation (RCA) gene family proteins and their relationship to microbial infection.Cell surface antigens in leukemias and lymphomas.The influence of C3-coated homologous erythrocytes on pokeweed-mitogen-induced polyclonal differentiation of human B cells.
P2860
Q24296010-BD0A51B3-AA8C-449B-9581-B793F408FA33Q24561504-09D55927-3E93-4350-8956-BE134B1FE52EQ24630380-B1B0656E-EF3A-454B-817B-C13CF4641E17Q24672100-FC268423-4095-48AD-911A-5A5C26BCDC94Q24676040-526191F7-DC7F-4317-8904-23D8B6AD5388Q24681646-309DD805-39E8-4B10-8D81-E9B3F7D38690Q24682508-127C1DD7-7262-44D1-8C42-C8585A823661Q33402381-639F5D80-B372-4D9E-B425-A4E9113FE4A5Q33682618-CD075B69-237C-4BE5-8DBD-B1BB22C009F5Q34094547-C880E3E2-ED9E-48B7-9FE5-9EDE336C5270Q34507790-7CC47A9E-3C42-48D2-96DF-0947264103C6Q34577064-ADC49714-E54B-4A28-81A3-A14920A43420Q34619233-2701B947-E65D-4F78-A3A2-FAFD8EF0EC14Q35002158-8C92B758-FCD6-4914-89AA-F7BFDCD91A38Q35819130-743930C7-F5FA-4B54-8B34-55185DBFA826Q35835299-FB6FFDBD-5EF2-4856-9DF7-2C51637E0F5EQ35836085-5B15B25E-41B1-4777-B354-C5DE6021576CQ35858151-78B46C62-1082-4547-BD42-F558BB657F9EQ36254495-B7617F4F-F27E-466D-A088-59BEE5A19122Q36273277-A7800BD1-8CD5-41AB-89D6-10E7EAB097FBQ36354741-839EDC4C-B2ED-46ED-8574-43F8DE9771B5Q36355255-A42FFA81-C1C4-4A20-8F76-84F5D1AE6E59Q36694813-14F551BF-1CE5-4792-9651-C17D7D2F4D9EQ36866420-3D17D607-4182-4C9D-9A0D-B06E197F9E31Q36903213-B1B6CFB9-35F7-4889-A328-FCDB817F936BQ36963833-65EF600E-4878-4918-9C4F-D298C5B04ACCQ36992874-E255B86E-C5BD-4FAB-A1C3-E1C25B7FD45FQ37128643-AF7AC175-6278-4C57-9440-D0C0DCE40F85Q37133741-2BBA6FB3-5F10-48D2-A06E-17D38972A639Q37546659-67B5F796-EC4D-49C2-A5D6-EB6FF0D8029FQ37677073-28F99754-802D-4986-A517-50ECA4F02F06Q37679591-6940BA36-C397-4EB3-B510-B75343D0E444Q37680761-04A84873-A6EB-4503-868A-0D1DB7F68D96Q37686904-4E824F8B-18A8-4351-981F-31961298085BQ37692311-71761159-2794-4574-83B3-20713AFEDD76Q38350695-71B58C2B-D97F-4633-B111-A057AB2DC060Q40343247-7934196D-0768-400B-9163-4969B8935CD2Q40416090-C7AE7718-FFC7-4AE4-865F-1A40508795F5Q40986836-436A2F17-FB8A-40DE-BC94-63D176405F3DQ41266502-E54E3C2A-7F18-4053-B21B-224166D63305
P2860
Identification of the membrane receptor for the complement fragment C3d by means of a monoclonal antibody.
description
1983 nî lūn-bûn
@nan
1983年の論文
@ja
1983年学术文章
@wuu
1983年学术文章
@zh-cn
1983年学术文章
@zh-hans
1983年学术文章
@zh-my
1983年学术文章
@zh-sg
1983年學術文章
@yue
1983年學術文章
@zh
1983年學術文章
@zh-hant
name
Identification of the membrane ...... eans of a monoclonal antibody.
@ast
Identification of the membrane ...... eans of a monoclonal antibody.
@en
type
label
Identification of the membrane ...... eans of a monoclonal antibody.
@ast
Identification of the membrane ...... eans of a monoclonal antibody.
@en
prefLabel
Identification of the membrane ...... eans of a monoclonal antibody.
@ast
Identification of the membrane ...... eans of a monoclonal antibody.
@en
P2093
P2860
P356
P1476
Identification of the membrane ...... eans of a monoclonal antibody.
@en
P2093
P2860
P304
P356
10.1084/JEM.158.4.1021
P407
P577
1983-10-01T00:00:00Z